Balancing novelty with confined chemical space in modern drug discovery

José L. Medina-Franco, Karina Martinez-Mayorga, Nathalie Meurice

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Introduction: The concept of chemical space has broad applications in drug discovery. In response to the needs of drug discovery campaigns, different approaches are followed to efficiently populate, mine and select relevant chemical spaces that overlap with biologically relevant chemical spaces. Areas covered: This paper reviews major trends in current drug discovery and their impact on the mining and population of chemical space. We also survey different approaches to develop screening libraries with confined chemical spaces balancing physicochemical properties. In this context, the confinement is guided by criteria that can be divided in two broad categories: i) library design focused on a relevant therapeutic target or disease and ii) library design focused on the chemistry or a desired molecular function. Expert opinion: The design and development of chemical libraries should be associated with the specific purpose of the library and the project goals. The high complexity of drug discovery and the inherent imperfection of individual experimental and computational technologies prompt the integration of complementary library design and screening approaches to expedite the identification of new and better drugs. Library design approaches including diversity-oriented synthesis, biological-oriented synthesis or combinatorial library design, to name a few, and the design of focused libraries driven by target/disease, chemical structure or molecular function are more efficient if they are guided by multi-parameter optimization. In this context, consideration of pharmaceutically relevant properties is essential for balancing novelty with chemical space in drug discovery.

Original languageEnglish (US)
Pages (from-to)151-165
Number of pages15
JournalExpert Opinion on Drug Discovery
Volume9
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Confined Spaces
Drug Discovery
Libraries
Chemical Phenomena
Small Molecule Libraries
Expert Testimony
Molecular Structure
Names
Technology

Keywords

  • Focused libraries
  • Multi-parameter optimization
  • Polypharmacology
  • Protein-protein interaction modulators
  • Targeted libraries

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Balancing novelty with confined chemical space in modern drug discovery. / Medina-Franco, José L.; Martinez-Mayorga, Karina; Meurice, Nathalie.

In: Expert Opinion on Drug Discovery, Vol. 9, No. 2, 02.2014, p. 151-165.

Research output: Contribution to journalArticle

Medina-Franco, José L. ; Martinez-Mayorga, Karina ; Meurice, Nathalie. / Balancing novelty with confined chemical space in modern drug discovery. In: Expert Opinion on Drug Discovery. 2014 ; Vol. 9, No. 2. pp. 151-165.
@article{b5e64a93cfa34358a88119b95483d0f8,
title = "Balancing novelty with confined chemical space in modern drug discovery",
abstract = "Introduction: The concept of chemical space has broad applications in drug discovery. In response to the needs of drug discovery campaigns, different approaches are followed to efficiently populate, mine and select relevant chemical spaces that overlap with biologically relevant chemical spaces. Areas covered: This paper reviews major trends in current drug discovery and their impact on the mining and population of chemical space. We also survey different approaches to develop screening libraries with confined chemical spaces balancing physicochemical properties. In this context, the confinement is guided by criteria that can be divided in two broad categories: i) library design focused on a relevant therapeutic target or disease and ii) library design focused on the chemistry or a desired molecular function. Expert opinion: The design and development of chemical libraries should be associated with the specific purpose of the library and the project goals. The high complexity of drug discovery and the inherent imperfection of individual experimental and computational technologies prompt the integration of complementary library design and screening approaches to expedite the identification of new and better drugs. Library design approaches including diversity-oriented synthesis, biological-oriented synthesis or combinatorial library design, to name a few, and the design of focused libraries driven by target/disease, chemical structure or molecular function are more efficient if they are guided by multi-parameter optimization. In this context, consideration of pharmaceutically relevant properties is essential for balancing novelty with chemical space in drug discovery.",
keywords = "Focused libraries, Multi-parameter optimization, Polypharmacology, Protein-protein interaction modulators, Targeted libraries",
author = "Medina-Franco, {Jos{\'e} L.} and Karina Martinez-Mayorga and Nathalie Meurice",
year = "2014",
month = "2",
doi = "10.1517/17460441.2014.872624",
language = "English (US)",
volume = "9",
pages = "151--165",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Balancing novelty with confined chemical space in modern drug discovery

AU - Medina-Franco, José L.

AU - Martinez-Mayorga, Karina

AU - Meurice, Nathalie

PY - 2014/2

Y1 - 2014/2

N2 - Introduction: The concept of chemical space has broad applications in drug discovery. In response to the needs of drug discovery campaigns, different approaches are followed to efficiently populate, mine and select relevant chemical spaces that overlap with biologically relevant chemical spaces. Areas covered: This paper reviews major trends in current drug discovery and their impact on the mining and population of chemical space. We also survey different approaches to develop screening libraries with confined chemical spaces balancing physicochemical properties. In this context, the confinement is guided by criteria that can be divided in two broad categories: i) library design focused on a relevant therapeutic target or disease and ii) library design focused on the chemistry or a desired molecular function. Expert opinion: The design and development of chemical libraries should be associated with the specific purpose of the library and the project goals. The high complexity of drug discovery and the inherent imperfection of individual experimental and computational technologies prompt the integration of complementary library design and screening approaches to expedite the identification of new and better drugs. Library design approaches including diversity-oriented synthesis, biological-oriented synthesis or combinatorial library design, to name a few, and the design of focused libraries driven by target/disease, chemical structure or molecular function are more efficient if they are guided by multi-parameter optimization. In this context, consideration of pharmaceutically relevant properties is essential for balancing novelty with chemical space in drug discovery.

AB - Introduction: The concept of chemical space has broad applications in drug discovery. In response to the needs of drug discovery campaigns, different approaches are followed to efficiently populate, mine and select relevant chemical spaces that overlap with biologically relevant chemical spaces. Areas covered: This paper reviews major trends in current drug discovery and their impact on the mining and population of chemical space. We also survey different approaches to develop screening libraries with confined chemical spaces balancing physicochemical properties. In this context, the confinement is guided by criteria that can be divided in two broad categories: i) library design focused on a relevant therapeutic target or disease and ii) library design focused on the chemistry or a desired molecular function. Expert opinion: The design and development of chemical libraries should be associated with the specific purpose of the library and the project goals. The high complexity of drug discovery and the inherent imperfection of individual experimental and computational technologies prompt the integration of complementary library design and screening approaches to expedite the identification of new and better drugs. Library design approaches including diversity-oriented synthesis, biological-oriented synthesis or combinatorial library design, to name a few, and the design of focused libraries driven by target/disease, chemical structure or molecular function are more efficient if they are guided by multi-parameter optimization. In this context, consideration of pharmaceutically relevant properties is essential for balancing novelty with chemical space in drug discovery.

KW - Focused libraries

KW - Multi-parameter optimization

KW - Polypharmacology

KW - Protein-protein interaction modulators

KW - Targeted libraries

UR - http://www.scopus.com/inward/record.url?scp=84893101922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893101922&partnerID=8YFLogxK

U2 - 10.1517/17460441.2014.872624

DO - 10.1517/17460441.2014.872624

M3 - Article

C2 - 24350718

AN - SCOPUS:84893101922

VL - 9

SP - 151

EP - 165

JO - Expert Opinion on Drug Discovery

JF - Expert Opinion on Drug Discovery

SN - 1746-0441

IS - 2

ER -